AvenCell

Watertown, MA · Founded 2021 · Privately Held (backing)

Developer of T cell-based immunotherapies intended to support cancer treatment. AvenCell is based in Watertown, MA and was founded in 2021. Its last reported valuation was $227 million in Oct 2024. It has raised $192 million.

Last reported valuation
$227.0M
Oct 2026
Priced at
—
Total raised
$192.4M
Last round
—

Who backs AvenCell?

10 investors
InvestorType
F-Prime CapitalVenture capital
Eight RoadsAsset manager
Novo HoldingsOther
NYBC VenturesVenture capital
Blackstone Life Sciences—
Cellex Cell Professionals—
Intellia Therapeutics—
JVC Investment Partners—
Japan Agency for Medical Research and Development—
Piper Sandler—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

AvenCell investors

10 investors are on record for AvenCell, including F-Prime Capital, Eight Roads, Novo Holdings and NYBC Ventures.

Free account
More of AvenCell with a free account
  • ·Watch AvenCell: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like AvenCell. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View